| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
4.225 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
DDX54 |
DDX54: ATP-dependent RNA helicase DDX54 |
4.225 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PSMA6 |
PSMA6, PROS27: Proteasome subunit alpha type-6 |
4.225 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
CENTB1 |
CENTB1, KIAA0050: Centaurin-beta 1 |
4.225 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
4.215 |
Evidence |
|
| SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
4.212 |
Evidence |
|
| DSTN |
DSTN, ACTDP, DSN: Destrin |
TMSL8 |
TMSL8, TMSNB: NB thymosin beta |
4.21 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
GPA33 |
GPA33: Cell surface A33 antigen precursor |
4.21 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
YWHAH |
YWHAH, YWHA1: 14-3-3 protein eta |
4.21 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
4.21 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
4.21 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
4.21 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
4.21 |
Evidence |
|
| HRG |
HRG: Histidine-rich glycoprotein precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
4.21 |
Evidence |
|
| IL2RA |
IL2RA: Interleukin-2 receptor alpha chain precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
4.21 |
Evidence |
|
| KNG1 |
IPI00215894 |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
4.21 |
Evidence |
|
| WASPIP |
IPI00552369 |
S100B |
S100B: Protein S100-B |
4.21 |
Evidence |
|
| TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
CAP1 |
CAP1, CAP: Adenylyl cyclase-associated protein 1 |
4.21 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
4.205 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
4.205 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
4.205 |
Evidence |
|
| SYNGAP1 |
SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
4.197 |
Evidence |
|
| SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
4.197 |
Evidence |
|
| TAOK1 |
TAOK1, KIAA1361, MAP3K16: Serine/threonine-protein kinase TAO1 |
EPB41L1 |
EPB41L1, KIAA0338: Band 4.1-like protein 1 |
4.197 |
Evidence |
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
TRERF1 |
TRERF1, BCAR2, RAPA, TREP132: Transcriptional-regulating factor 1 |
4.197 |
Evidence |
|